Literature DB >> 2890254

[Sensorimotor polyneuropathy induced by almitrine dimesylate. Anatomo-clinical study of a case].

J J Rousseau1, C A Lust, J M Brucher.   

Abstract

A 65-year-old male patient with chronic obstructive long disease developed a severe motor and sensory polyneuropathy during the treatment with almitrine bismesylate (Vectarion). Electrophysiological and neuropathological investigations demonstrated a distal axonopathy. A medicamentous origin was suspected since other causal factors were lacking. Eight months after stopping of treatment, the functional recovery was complete. The authors discuss the recent data recorded in the literature concerning the neurological complications induced by this new drug, which is increasingly administered in diseases of the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890254

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  2 in total

1.  Peripheral neuropathies during treatment with almitrine: report of 46 cases.

Authors:  P Bouche; L Lacomblez; J M Leger; M P Chaunu; H Ratinahirana; P Brunet; J J Hauw; H P Cathala; D Laplane
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

2.  Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS.

Authors:  Hojae Lee; Jae Jin Lee; Na Young Park; Sandeep Kumar Dubey; Taeyong Kim; Kai Ruan; Su Bin Lim; Seong-Hyun Park; Shinwon Ha; Irina Kovlyagina; Kyung-Tai Kim; Seongjun Kim; Yohan Oh; Hyesoo Kim; Sung-Ung Kang; Mi-Ryoung Song; Thomas E Lloyd; Nicholas J Maragakis; Young Bin Hong; Hyungjin Eoh; Gabsang Lee
Journal:  Nat Neurosci       Date:  2021-11-15       Impact factor: 28.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.